Understanding the US FDA Drug Review and Approval Process

  • Speaker:Dr. David Lim
  • Date: 13th December 2017 10:00 AM PST | 01:00 PM EST
  • Duration:60Min
  • Product Code:GRC-90199

$169

20

DAYS
Left to Register

refer

Refer Friend's


Live Session - How it works

  • Username and Password will be sent to you 24 hours prior to the webinar.
  • Presentation handouts in pdf format will be mailed to you.
  • Login to the session using the username and password provided to you.
  • Get answer to your queries through interactive Q&A sessions via chat.
  • Please let us know your thoughts and views at the end of webinar, your valuable feedback will help us improve.
  • Get certification of attendance.

Recorded Session - How it works

  • Login Information with Password to view the webinar, 24 hours after the Live webinar (link valid for 6 months).
  • A link will be provided to you upon purchase of the recorded session.
  • Please click on the link to access the session.
  • Presentation handouts in pdf format will be mailed to you.
  • Get certification of attendance.

Training CD - How it works

  • Free shipment within 72 Hours, from the date of webinar completion.

(More about our products contact +1- 248-233-2049)

Why should you attend :

The FDA’s Center for Drug Evaluation and Research (CDER) is responsible for reviewing and approving both prescription and nonprescription or over-the-counter (OTC) drugs.

To introduce a new drug product into the U.S. market, some firms submit a new drug application (NDA) to the US FDA/CDER.

The firms are responsible for testing a drug and for submitting evidence that the drug is safe and effective.

In 2014 and 2015, the FDA/CDER has approved 41 and 45 novel drugs, respectively.

This webinar is intended to help you better understand FDA’s drug review and approval process. The FDA’s recent approvals of novel drugs will also be discussed.

The speaker will walk you through the regulatory requirements for FDA’s drug review and approvals.

Areas Covered in the Session:
  • Laws.
  • Regulations.
  • FDA Guidances.
  • Definitions.
  • Regulatory Requirements for New Drug Application (NDA) and Biologics License Application (BLA).
  • Drug Development.
  • FDA Drug Review and Approval.
  • Common Mistakes.
  • Critical Considerations.
  • Enforcement Actions.
  • Recent FDA Approvals.
  • PASS-IT Recommendations.
Who will benefit :
  • CEOs.
  • VPs.
  • Compliance Officers.
  • Attorneys.
  • Regulatory Affairs.
  • Clinical Affairs.
  • Quality Assurance.
  • R&D.
  • Consultants.
  • Contractors/Subcontractors.
  • Anyone Interested in the FDA Drug Review and Approval Processes.
Instructor Profile:

Dr. David Lim, Ph.D., RAC, ASQ-CQA. Dr. Lim is President and Principal of Regulatory Doctor. As a leading industry speaker, Dr. Lim frequently presents global regulatory and quality compliance topics in various forums and meetings. Recently, Dr. Lim developed 510(k) templates ready for use compliant with e-Copy and RTA policy. In addition, Dr. Lim developed FDA inspection checklists for drug and medical device manufacturers based on his analysis of FDA inspectional observations cited in 483s for the past eight years. Dr. Lim provides his feedback to regulatory agency (e.g., US FDA) through public comments and also served as a panel member during the FDA’s transparency public meeting in 2009.

Dr. Lim contributes to the Regulatory Affairs Professional Society (RAPS) as an author and speaker. Dr. Lim leads and directs all research projects including pharmacovigilance, medical device reporting, recalls and patient safety signals being conducted at the Regulatory Doctor. Dr. Lim currently serves as a member of the Advisory Board for Inspection Insider published by FDA News.

Available Options

Live Webinar: Attend the meeting Live online via Webex

$169

Recording: Access it for 6 months from any location

$259

CD: Shipped within 2 working days

$339

Live + Recording: Attend Live + Access the recording for 6 months

$289

5 Member Group: Access the Live Meeting online from any location globally

$769

10 Member group: Access the Live Meeting online from any location globally

$1,389

Live + CD: Attend Live + Get a copy of the CD of the webinar

$389
For discounts and offers call support

Related Products

510(K) Submission - A Comprehensive and an Updated Overview

510(K) Submission - A Comprehensive and an Updated Overview

We offer face to face and online training. If you have 5 or more people interested in learning this topic. Contact our support to set up a date. Why should you attend:The section [510(k)] of the Federal Food, Drug, and Cosmetic Act (FD&C Act or the Act) prescribes the premarket notification requirements. The premarket notification [510(k)] is the most common pathway to market for medical devices including in vitro diagnostic medical devices (IVDs).  The 510(k) premarket submission ..

$239

Implementing a Unique Device Identification (UDI) System

Implementing a Unique Device Identification (UDI) System

Description : This webinar will discuss the regulatory and compliance requirements to implement a system for Unique Device Identification (UDI) including final rules, compliance dates and requirements. The speaker will walk you through the requirements including, but not limited to, what to consider when implementing a UDI system in a proactive, streamlined manner. This seminar is intended to help you effectively implement a unique device identification (UDI) system (UDI system) based on th..

$209

Root Cause Analysis and CAPA

Root Cause Analysis and CAPA

We offer face to face and online training. If you have 5 or more people interested in learning this topic. Contact our support to set up a date. Description: Conducting an effective root cause analysis can be a daunting task. And without a good root cause analysis, your CAPA will not result in the desired improvement. This webinar will give you insights and lessons learned from an industry expert with over 30 years’ experience. You will learn how to get permanent resolution to your seri..

$219